ArticleLaboratory investigation; a journal of technical methods and pathology2016

Recombinant IL-33 prolongs leflunomide-mediated graft survival by reducing IFN-γ and expanding CD4(+)Foxp3(+) T cells in concordant heart transplantation.

Chen Dai et al.PubMed ↗Publisher ↗

No numbers read from the abstract.